These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9741431)

  • 1. Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy.
    Yang Q; Mamounas M; Yu G; Kennedy S; Leaker B; Merson J; Wong-Staal F; Yu M; Barber JR
    Hum Gene Ther; 1998 Sep; 9(13):1929-37. PubMed ID: 9741431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.
    Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Wenz F; Fruehauf S; Zeller WJ; Veldwijk MR
    Exp Hematol; 2008 Aug; 36(8):957-64. PubMed ID: 18495326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV.
    Nathwani AC; Hanawa H; Vandergriff J; Kelly P; Vanin EF; Nienhuis AW
    Gene Ther; 2000 Feb; 7(3):183-95. PubMed ID: 10694794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quiescent subpopulations of human CD34-positive hematopoietic stem cells are preferred targets for stable recombinant adeno-associated virus type 2 transduction.
    Paz H; Wong CA; Li W; Santat L; Wong KK; Chatterjee S
    Hum Gene Ther; 2007 Jul; 18(7):614-26. PubMed ID: 17638572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recombinant adeno-associated virus vector related impurities].
    Diao Y; Wang Q; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells.
    Miller JL; Donahue RE; Sellers SE; Samulski RJ; Young NS; Nienhuis AW
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10183-7. PubMed ID: 7524085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term genetic modification of rhesus monkey hematopoietic cells following transplantation of adenoassociated virus vector-transduced CD34+ cells.
    Schimmenti S; Boesen J; Claassen EA; Valerio D; Einerhand MP
    Hum Gene Ther; 1998 Dec; 9(18):2727-34. PubMed ID: 9874271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.
    Benedict CA; Tun RY; Rubinstein DB; Guillaume T; Cannon PM; Anderson WF
    Hum Gene Ther; 1999 Mar; 10(4):545-57. PubMed ID: 10094198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transduction efficiency of recombinant adeno-associated virus 2 in human umbilical cord blood CD34+ hematopoietic stem/progenitor cells].
    Chen Y; Chen FP; Peng JQ; Wu XB; Wu XH; Fu G
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):576-8. PubMed ID: 14706137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
    Muzyczka N; Warrington KH
    Hum Gene Ther; 2005 Apr; 16(4):408-16. PubMed ID: 15871672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors.
    Handa A; Muramatsu SI; Qiu J; Mizukami H; Brown KE
    J Gen Virol; 2000 Aug; 81(Pt 8):2077-2084. PubMed ID: 10900047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors.
    Schuhmann NK; Pozzoli O; Sallach J; Huber A; Avitabile D; Perabo L; Rappl G; Capogrossi MC; Hallek M; Pesce M; Büning H
    Exp Hematol; 2010 Sep; 38(9):707-17. PubMed ID: 20447441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors.
    Gonçalves MA; Pau MG; de Vries AA; Valerio D
    Virology; 2001 Sep; 288(2):236-46. PubMed ID: 11601895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.
    Clark KR; Voulgaropoulou F; Johnson PR
    Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors.
    Chatterjee S; Li W; Wong CA; Fisher-Adams G; Lu D; Guha M; Macer JA; Forman SJ; Wong KK
    Blood; 1999 Mar; 93(6):1882-94. PubMed ID: 10068661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.
    Harding TC; Dickinson PJ; Roberts BN; Yendluri S; Gonzalez-Edick M; Lecouteur RA; Jooss KU
    Hum Gene Ther; 2006 Aug; 17(8):807-20. PubMed ID: 16942441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5.
    Zhong L; Li W; Li Y; Zhao W; Wu J; Li B; Maina N; Bischof D; Qing K; Weigel-Kelley KA; Zolotukhin I; Warrington KH; Li X; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2006 Mar; 17(3):321-33. PubMed ID: 16544981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.